ipriflavone has been researched along with Lymphopenia in 1 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
Lymphopenia: Reduction in the number of lymphocytes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexandersen, P | 1 |
| Toussaint, A | 1 |
| Christiansen, C | 1 |
| Devogelaer, JP | 1 |
| Roux, C | 1 |
| Fechtenbaum, J | 1 |
| Gennari, C | 1 |
| Reginster, JY | 1 |
1 trial available for ipriflavone and Lymphopenia
| Article | Year |
|---|---|
Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.
Topics: Aged; Analysis of Variance; Biomarkers; Bone Density; Bone Remodeling; Double-Blind Method; Female; | 2001 |